High-dose Lipitor cuts CV risk 27% in bypass patients
Key points
- World drug giant Pfizer's Lipitor (atorvastatin calcium) 80mg significantly reduced the risk of major cardiovascular events, including heart attack and stroke, by 27% in patients with heart disease who had previous coronary bypass surgery compared with subjects taking the 10mg dose of the drug.
- Intensive Lipitor therapy also provided a significant 30% reduction in the need for either repeat coronary bypass surgery or angioplasty, another type of interventional heart surgery, compared with Lipitor 10mg, the firm noted.
- Each year in the USA, approximately 470,000 bypass surgeries are performed on 270,000 people.
- This analysis, designed and completed following the closure of the five-year Treating to New Targets study, was published in a recent issue of the Journal of the American College of Cardiology.
World drug giant Pfizer's Lipitor (atorvastatin calcium) 80mg significantly reduced the risk of major cardiovascular events, including heart attack and stroke, by 27% in patients with heart disease who had previous coronary bypass surgery compared with subjects taking the 10mg dose of the drug. This analysis, designed and completed following the closure of the five-year Treating to New Targets study, was published in a recent issue of the Journal of the American College of Cardiology.
Intensive Lipitor therapy also provided a significant 30% reduction in the need for either repeat coronary bypass surgery or angioplasty, another type of interventional heart surgery, compared with Lipitor 10mg, the firm noted.
Each year in the USA, approximately 470,000 bypass surgeries are performed on 270,000 people. Patients in the TNT study who had undergone previous bypass surgery had a much higher likelihood of cardiovascular events than those who did not. This especially high-risk population tends to be under-treated with lipid-lowering therapy, Pfizer stated.
Marketletter - May. 26, 2008
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Heart & Blood Vessels →
NewsNew Blood Thinner May Lower Chances of Clots in High-Risk Heart Patients: FDA
The new blood thinner Xarelto appears to lower the chances of potentially fatal blood clots in high-risk heart patients, a U.S. Food and Drug Administration review has found. The review came in briefing documents that…
22 May 2012
NewsDeath risks higher for heart attack survivors living near major roadways
Heart attack survivors who live about 100 meters (328 feet) or less from a major U.S. roadway face increased risk of death from all causes, according to new research in the American Heart Association's journal…
8 May 2012
NewsEven at higher genetic heart risk, lifestyle helps
It's no secret that healthy habits do your heart good. But a new study helps confirm that lifestyle also matters for people who have a genetically increased risk of heart problems. The study, reported in the American…
